Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0BWCTV
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
ARX-305
|
|||||
| Synonyms |
ARX305; ARX 305; NCB-002
Click to Show/Hide
|
|||||
| Organization |
Ambrx, Inc.; Zhejiang Medicine Co., Ltd.; Novocodex Biopharmaceuticals Co., Ltd.
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 3 Indication(s)
Hematologic cancer [ICD11:2B3Z]
Phase 1
Kidney cancer [ICD11:2C90-2C91]
Phase 1
Multiple myeloma [ICD11:2A83]
Phase 1
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
CD70 antigen (CD70)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.